{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T16:11:45Z","timestamp":1783181505699,"version":"3.54.6"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.brachy.2025.06.004","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T20:26:22Z","timestamp":1753388782000},"page":"663-669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Canadian brachytherapy experience: Results of the Canadian brachytherapy group national survey"],"prefix":"10.1016","volume":"24","author":[{"given":"Kevin","family":"Martell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Keyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ericka","family":"Wiebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Vigneault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandeep","family":"Taggar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2025.06.004_bib0001","doi-asserted-by":"crossref","first-page":"581","DOI":"10.5114\/jcb.2017.72607","article-title":"Current status of brachytherapy in cancer treatment \u2013 short overview","volume":"9","author":"Skowronek","year":"2017","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2025.06.004_bib0002","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1200\/JCO.2014.59.8128","article-title":"Brachytherapy: where has it gone?","volume":"33","author":"Petereit","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2025.06.004_bib0003","first-page":"386","article-title":"Brachytherapy: an overview for clinicians","volume":"69","author":"Chargari","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.brachy.2025.06.004_bib0004","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.prro.2021.09.013","article-title":"Changing landscape of radiation therapy for advanced cervical cancer with a focus on interstitial brachytherapy: a Canadian practice patterns survey","volume":"12","author":"Taggar","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.brachy.2025.06.004_bib0005","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.brachy.2021.07.002","article-title":"Utilization of brachytherapy in Quebec","volume":"20","author":"Lecavalier-Barsoum","year":"2021","journal-title":"Canada. Brachyther"},{"key":"10.1016\/j.brachy.2025.06.004_bib0006","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijrobp.2023.11.007","article-title":"Updated trends in the utilization of brachytherapy in cervical cancer in the United States: a surveillance, epidemiology, and end-results study","volume":"119","author":"Han","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.06.004_bib0007","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.radonc.2020.07.036","article-title":"Is prostate brachytherapy a dying art? Trends and variation in the definitive management of prostate cancer in Ontario","volume":"152","author":"Corkum","year":"2020","journal-title":"Canada. Radiother Oncol"},{"key":"10.1016\/j.brachy.2025.06.004_bib0008","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijrobp.2017.09.004","article-title":"Evaluation of delivery costs for external beam radiation therapy and brachytherapy for locally advanced cervical cancer using time-driven activity-based costing","volume":"100","author":"Bauer-Nilsen","year":"2018","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"key":"10.1016\/j.brachy.2025.06.004_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.brachy.2024.11.011","article-title":"How do you do it?: gynecologic brachytherapy best practices at high volume institutions within the United States and Canada","author":"Small","year":"2025","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.06.004_bib0010","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.brachy.2020.07.002","article-title":"More than learning technical skills: the importance of mentorship and coaching during a brachytherapy fellowship","volume":"19","author":"Croke","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.06.004_bib0011","doi-asserted-by":"crossref","first-page":"501","DOI":"10.5114\/jcb.2022.123969","article-title":"Resident training in brachytherapy in France: a 10-year update after the first survey of SFJRO members","volume":"14","author":"Kissel","year":"2022","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2025.06.004_bib0012","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.brachy.2020.08.001","article-title":"A guide to curriculum inquiry for brachytherapy simulation-based medical education","volume":"19","author":"Fernandez","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.06.004_bib0013","first-page":"1","article-title":"Establishing a simulation-based education program for radiation oncology learners in permanent seed implant brachytherapy: building validation evidence","volume":"1","author":"Roumeliotis","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.06.004_bib0014","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.brachy.2020.05.004","article-title":"Brachytherapy education and certification-A Canadian approach","volume":"19","author":"Morton","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.06.004_bib0015","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"The Lancet"},{"key":"10.1016\/j.brachy.2025.06.004_bib0016","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijrobp.2017.01.008","article-title":"ASCENDE-RT: an analysis of treatment-related morbidity for a randomized trial comparing a low-dose-rate brachytherapy boost with a dose-escalated external beam boost for high- and intermediate-risk prostate cancer","volume":"98","author":"Rodda","year":"2017","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"key":"10.1016\/j.brachy.2025.06.004_bib0017","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijrobp.2024.02.064","article-title":"A randomized trial comparing quality of life after low-dose rate or high-dose rate prostate brachytherapy boost with pelvic external beam radiation therapy","volume":"120","author":"Crook","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.06.004_bib0018","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.brachy.2020.10.007","article-title":"Complications and side effects of high-dose-rate prostate brachytherapy","volume":"20","author":"Martell","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.06.004_bib0019","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ijrobp.2017.05.045","article-title":"Multicenter evaluation of biochemical relapse\u2013Free survival outcomes for intraoperatively planned prostate brachytherapy using an automated delivery system","volume":"99","author":"Martell","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.06.004_bib0020","doi-asserted-by":"crossref","first-page":"463","DOI":"10.5489\/cuaj.1482","article-title":"Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer: a systematic review","volume":"7","author":"Rodrigues","year":"2013","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.brachy.2025.06.004_bib0021","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/cncr.27911","article-title":"Population-based 10-year oncologic outcomes after low-dose-rate brachytherapy for low-risk and intermediate-risk prostate cancer","volume":"119","author":"Morris","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2025.06.004_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110381","article-title":"Prostate high dose-rate brachytherapy as monotherapy for low and intermediate-risk prostate cancer: efficacy results from a randomized phase II clinical trial of one fraction of 19 gy or two fractions of 13.5 gy: a 9-year update","volume":"198","author":"Hudson","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2025.06.004_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110426","article-title":"Single\u2013dose high-dose-rate brachytherapy versus two and three fractions for locally advanced prostate cancer","volume":"199","author":"Hoskin","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2025.06.004_bib0024","doi-asserted-by":"crossref","first-page":"E615","DOI":"10.1503\/cmaj.240095","article-title":"Projected estimates of cancer in Canada in 2024","volume":"196","author":"Brenner","year":"2024","journal-title":"CMAJ"},{"key":"10.1016\/j.brachy.2025.06.004_bib0025","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2025.06.004_bib0026","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jamaoncol.2024.3089","article-title":"Stereotactic vs hypofractionated radiotherapy for inoperable stage I non\u2013Small cell lung cancer","volume":"10","author":"Swaminath","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.brachy.2025.06.004_bib0027","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","article-title":"Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials","volume":"16","author":"Chang","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2025.06.004_bib0028","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1470-2045(18)30896-9","article-title":"Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial","volume":"20","author":"Ball","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2025.06.004_bib0029","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.annonc.2024.06.015","article-title":"Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy in locally advanced rectal cancer (UNION): early outcomes of a multicenter randomized phase III trial","volume":"35","author":"Lin","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.brachy.2025.06.004_bib0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.radonc.2017.08.011","article-title":"Hypofractionated radiation therapy for basal and squamous cell skin cancer: a meta-analysis","volume":"125","author":"Zaorsky","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2025.06.004_bib0031","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14153665","article-title":"MORPHEUS Phase II\u2013III study: a pre-planned interim safety analysis and preliminary results","volume":"14","author":"Garant","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.brachy.2025.06.004_bib0032","article-title":"Dose escalation using Contact X-Ray brachytherapy (Papillon) boost with chemoradiotherapy to improve organ preservation in early cT2-T3 rectal adenocarcinoma","author":"Gerard","year":"2022","journal-title":"Three-year Results of the phase 3 randomized OPERA Trial"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125001060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125001060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T03:09:27Z","timestamp":1756436967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472125001060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1538472125001060"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2025.06.004","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Canadian brachytherapy experience: Results of the Canadian brachytherapy group national survey","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2025.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}